Xiao-Hui Chen
CIK: 0002106182
Transaction Breakdown
Open Market Buys (P)0
High conviction signal
Open Market Sales (S)0
Position reduction
Option Exercises (M)0
Derivative conversions
Awards (A)0
Compensation grants
Other (G, F, J, C, D, …)0
Gifts, tax withholding, conversions, dispositions to the issuer and other codes
Companies & Roles (1)
BLTE
BELITE BIO, INC
Director
Discretionary Trading P&L
Holdings
Transaction History (0 total)
1 Form 3 filing on record — initial statements of ownership, which report holdings, not trades. No Form 4 or Form 5 transactions since Sep 2024.
| Type | Shares | Price | Ownership | |||
|---|---|---|---|---|---|---|
| 1 Form 3 filing on record — initial statements of ownership, which report holdings, not trades. No Form 4 or Form 5 transactions since Sep 2024. | ||||||
0-0 of 0 transactions
About Chen Xiao-Hui
Chen Xiao-Hui (SEC CIK 0002106182) files insider reports with the SEC as Director of BELITE BIO, INC (BLTE).
Signal8 holds 1 ownership filing by Chen Xiao-Hui, a Form 3, filed on Mar 18, 2026. A Form 3 is an initial statement of ownership: it reports holdings, not trades, so no Form 4 or Form 5 transactions are on record since Sep 2024.
The business address on Chen Xiao-Hui's filings is in TAIPEI CITY.
Other insiders filing for BELITE BIO, INC (BLTE)
- Chuang Hao-Yuan, Chief Financial Officer
- Lin Yu-Hsin, Chief Executive Officer
- Chen Wan-Shan, Director
- Scholl Hendrik Peter, Chief Medical Officer
- MATA NATHAN L., Chief Scientific Officer
- Longo John Michael, Director